NVAXNovavax Inc
NVAX
Novavax Inc107,058
Mkt Cap
$1.11BVolume
1,531.0052W High
$11.5552W Low
$5.01PE Ratio
3.71NVAX Fundamentals
Price
$6.57Prev Close
$6.80Open
$6.6150D MA
$8.30Beta
1.51Avg. Volume
4.42MEPS (Annual)
-$1.23P/B
-6.81Rev/Employee
$716,556.72Novavax, Inc. (NASDAQ:NVAX) Receives Consensus Recommendation of "Hold" from Brokerages
Shares of Novavax, Inc. (NASDAQ:NVAX - Get Free Report) have earned a consensus recommendation of "Hold" from the nine research firms that are covering the stock, Marketbeat Ratings reports. Four...
MarketBeat·4d ago
Quinn Opportunity Partners LLC Has $1.20 Million Holdings in Novavax, Inc. $NVAX
Quinn Opportunity Partners LLC lifted its position in Novavax, Inc. (NASDAQ:NVAX - Free Report) by 63.8% in the 2nd quarter, according to the company in its most recent filing with the SEC. The...
MarketBeat·5d ago
Campbell & CO Investment Adviser LLC Takes $1.19 Million Position in Novavax, Inc. $NVAX
Campbell & CO Investment Adviser LLC acquired a new position in shares of Novavax, Inc. (NASDAQ:NVAX - Free Report) in the second quarter, according to its most recent filing with the Securities...
MarketBeat·5d ago
B. Riley Issues Pessimistic Outlook for Novavax Earnings
Novavax, Inc. (NASDAQ:NVAX - Free Report) - Equities research analysts at B. Riley decreased their Q4 2025 EPS estimates for shares of Novavax in a research note issued on Monday, November 10th. B...
MarketBeat·6d ago
Novavax to Participate in Jefferies London Healthcare Conference
Novavax to Participate in Jefferies London Healthcare Conference Novavax to Participate in Jefferies London Healthcare Conference PR Newswire GAITHERSBURG, Md., Nov. 12, 2025 GAITHERSBURG, Md., Nov...
PR Newswire·7d ago
Novavax, Inc. (NVAX) is Attracting Investor Attention: Here is What You Should Know
Recently, Zacks.com users have been paying close attention to Novavax (NVAX). This makes it worthwhile to examine what the stock has in store.
Zacks·8d ago
Cantor Fitzgerald Raises Earnings Estimates for Novavax
Novavax, Inc. (NASDAQ:NVAX - Free Report) - Research analysts at Cantor Fitzgerald raised their FY2025 earnings per share (EPS) estimates for shares of Novavax in a research report issued on Friday...
MarketBeat·9d ago
Wall Street Zen Downgrades Novavax (NASDAQ:NVAX) to Sell
Wall Street Zen cut Novavax from a "hold" rating to a "sell" rating in a research report on Saturday...
MarketBeat·10d ago
Novavax Q3 Earnings & Revenues Beat Estimates, '25 Sales View Raised
NVAX exceeds third-quarter expectations, boosted by a Sanofi milestone payment. It lifts its 2025 sales outlook.
Zacks·12d ago